NO302749B1 - Desferrioksamin-B-salter og anvendelse av disse for fremstilling av farmasöytiske sammensetninger - Google Patents

Desferrioksamin-B-salter og anvendelse av disse for fremstilling av farmasöytiske sammensetninger

Info

Publication number
NO302749B1
NO302749B1 NO944617A NO944617A NO302749B1 NO 302749 B1 NO302749 B1 NO 302749B1 NO 944617 A NO944617 A NO 944617A NO 944617 A NO944617 A NO 944617A NO 302749 B1 NO302749 B1 NO 302749B1
Authority
NO
Norway
Prior art keywords
pct
desferrioxamine
salts
preparation
pharmaceutical compositions
Prior art date
Application number
NO944617A
Other languages
English (en)
Norwegian (no)
Other versions
NO944617D0 (no
NO944617L (no
Inventor
Nicholas Lowther
Ian Francis Hassan
Ian Timothy William Matthews
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO944617D0 publication Critical patent/NO944617D0/no
Publication of NO944617L publication Critical patent/NO944617L/no
Publication of NO302749B1 publication Critical patent/NO302749B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO944617A 1992-06-03 1994-12-01 Desferrioksamin-B-salter og anvendelse av disse for fremstilling av farmasöytiske sammensetninger NO302749B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929211779A GB9211779D0 (en) 1992-06-03 1992-06-03 Amine salts
PCT/GB1993/000940 WO1993024451A1 (en) 1992-06-03 1993-05-06 Desferrioxamine-b salts and their use as orally effective iron chelators

Publications (3)

Publication Number Publication Date
NO944617D0 NO944617D0 (no) 1994-12-01
NO944617L NO944617L (no) 1995-01-05
NO302749B1 true NO302749B1 (no) 1998-04-20

Family

ID=10716488

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944617A NO302749B1 (no) 1992-06-03 1994-12-01 Desferrioksamin-B-salter og anvendelse av disse for fremstilling av farmasöytiske sammensetninger

Country Status (17)

Country Link
US (2) US5739167A (ru)
EP (1) EP0643690B1 (ru)
JP (1) JPH07507288A (ru)
KR (1) KR950701907A (ru)
AT (1) ATE166342T1 (ru)
AU (1) AU672607B2 (ru)
CA (1) CA2135394A1 (ru)
DE (1) DE69318711T2 (ru)
DK (1) DK0643690T3 (ru)
ES (1) ES2117132T3 (ru)
FI (1) FI945654A (ru)
GB (1) GB9211779D0 (ru)
HK (1) HK1009330A1 (ru)
NO (1) NO302749B1 (ru)
NZ (1) NZ252738A (ru)
TW (1) TW230203B (ru)
WO (1) WO1993024451A1 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR009655A1 (es) * 1996-12-10 2000-04-26 Novartis Ag Una composicion parenteralmente inyectable, un metodo para su preparacion, metodos para el tratamiento de enfermedades, una modificacion decristal de 1-decansulfonato de desferrioxamina, su uso, un proceso para la produccion de dicha modificacion de cristal y una preparacion farmaceutica que
US7045531B1 (en) 1997-03-11 2006-05-16 The General Hospital Corporation Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
GB9727224D0 (en) * 1997-12-23 1998-02-25 Nycomed Imaging As Method
US6323218B1 (en) 1998-03-11 2001-11-27 The General Hospital Corporation Agents for use in the treatment of Alzheimer's disease
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
GB0117645D0 (en) 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
WO2008020920A1 (en) * 2006-08-15 2008-02-21 Duke University Ros-sensitive iron chelators and methods of using the same
US7932326B2 (en) * 2008-04-16 2011-04-26 The University Of Kentucky Research Foundation Chelating compounds and immobilized tethered chelators
US9259670B2 (en) 2008-04-16 2016-02-16 The University Of Kentucky Research Foundation Flow-through filter to remove aluminum from medical solutions
US9139456B2 (en) 2008-04-16 2015-09-22 The Curators Of The University Of Missouri Chelating compounds and immobilized tethered chelators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH438351A (de) * 1959-09-25 1967-06-30 Ciba Geigy Verfahren zur Herstellung neuer Wuchsstoffe
FR1898M (fr) * 1961-04-07 1963-07-08 Ciba Geigy Nouvelle substance utilisable en thérapeutique.
US3679660A (en) * 1969-06-09 1972-07-25 Agatha C Magnus Glucosamine-alkylsulfonate and process
US3652411A (en) * 1969-12-04 1972-03-28 Mobil Oil Corp Polyglycol base lubricant
US4419365A (en) * 1981-12-21 1983-12-06 Ciba-Geigy Corporation Method of treating Alzheimer's disease
US4684482A (en) * 1984-01-26 1987-08-04 Oral-D (L.P.) Orally effective ion chelators
IT1173992B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale
MX12394A (es) * 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.
AU1996192A (en) * 1991-05-13 1992-12-30 Oral-D Substituted orally effective ion chelators related to deferoxamine

Also Published As

Publication number Publication date
NO944617D0 (no) 1994-12-01
ES2117132T3 (es) 1998-08-01
DK0643690T3 (da) 1999-01-25
EP0643690A1 (en) 1995-03-22
KR950701907A (ko) 1995-05-17
NZ252738A (en) 1996-08-27
EP0643690B1 (en) 1998-05-20
TW230203B (ru) 1994-09-11
NO944617L (no) 1995-01-05
FI945654A0 (fi) 1994-11-30
ATE166342T1 (de) 1998-06-15
CA2135394A1 (en) 1993-12-09
JPH07507288A (ja) 1995-08-10
WO1993024451A1 (en) 1993-12-09
GB9211779D0 (en) 1992-07-15
DE69318711D1 (de) 1998-06-25
US5739167A (en) 1998-04-14
HK1009330A1 (en) 1999-05-28
AU4270093A (en) 1993-12-30
DE69318711T2 (de) 1998-11-19
US5663201A (en) 1997-09-02
AU672607B2 (en) 1996-10-10
FI945654A (fi) 1994-11-30

Similar Documents

Publication Publication Date Title
ATE163418T1 (de) Risperidon pamoate
DE69104723D1 (de) Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
DE69030206D1 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
NO302749B1 (no) Desferrioksamin-B-salter og anvendelse av disse for fremstilling av farmasöytiske sammensetninger
IL98133A0 (en) Sulphonyl substituted benzo-naphthyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HUT56092A (en) Process for producing 2-amino-pyrimidine-4-carboxamide derivatives and pharmaceutical compositions containing them
GB9126725D0 (en) Process
NO972028D0 (no) Kjemiske forbindelser og antikonsepsjonsmidler inneholdende disse
MY132057A (en) Quinoxalinones, a process for their preparation and their use
ATE70837T1 (de) Allylmercaptoacetyl-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ATE173471T1 (de) Pyridazinonderivate oder deren salze, verfahren zu ihrer herstellung und diese enthaltende antischockmittel
DE58902228D1 (de) Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten.
IL103855A0 (en) 5,6-dihydro-dibenz(b,e)azepin-6,11-dione-11-oximes,their preparation and pharmaceutical compositions containing them
AU1466592A (en) Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
AU1459192A (en) Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
ES8606272A1 (es) Procedimiento para preparar derivados carboxialquildipepti- dicos
DK0463139T3 (da) 2,13-disubstituerede ergoliner, deres fremstilling og deres anvendelse i lægemidler

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2000